Premium
CLINICAL TRIAL OF GLYBENCLAMIDE, A HYPOGLYCAEMIC AGENT
Author(s) -
Walker R. L.
Publication year - 1970
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/j.1326-5377.1970.tb63321.x
Subject(s) - medicine , clinical trial , diabetes mellitus , endocrinology
Glybenclamide was prescribed for 30 diabetic patients, aged 31 to 79 years, for a period of 25 to 50 weeks on a dosage ranging from 5 to 20 mg daily. Effective diabetic control was obtained in 66% of patients with a minimum of side effects.